Categories AlphaGraphs, Earnings, Health Care
Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights
Adjusts 2022 GAAP EPS Guidance; Reaffirms Non-GAAP EPS Guidance
Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today.
Total revenue grew 2% year-over-year to $11.9 billion.
Net earnings attributable to BMY shareholders stood at $1.4 billion, or $0.66 per share vs. $1.1 billion, or $0.47 per share for the same period a year ago.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
